A Study LY2228820 for Recurrent Ovarian Cancer

Clinical trial NCT01663857 · COMPLETED

Trial details

NCT number: NCT01663857
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2012-07-01
Primary completion: 2017-05-25
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.